mRNA |
MGCD-265 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
6e-06 |
mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
6e-06 |
mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
6e-06 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
7e-06 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
7e-06 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
7e-06 |
mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
0.27 |
9e-06 |
mRNA |
ATRA |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-05 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-05 |
mRNA |
BRD-A71883111 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-05 |